Lupin to focus on launch of biosimilar, inhalation product in US this fiscal Medical Dialogues Bureau15 July 2019 4:15 AMCoupling this with the building of Solosec brand in the US, NaMuscla in Europe and Bipresso in Japan will help Lupin drive sustainable growth, they...